Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.63 |
| ▸ | CCR1 | P32246 | 2/20 | 0.58 |
| ▸ | CCR5 | P51681 | 2/20 | 0.58 |
| ▸ | CCR8 | P51685 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.52 |
| ▸ | NCK1 | P16333 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | NQO2 | P16083 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.42 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13072274 | 0.85 | CYP1A2 (0.52) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL4572536 | 0.84 | CYP1A2 (0.65) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL12990548 | 0.83 | ALDH1A1 (0.52) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL12991057 | 0.81 | CYP1A2 (0.57) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL8268977 | 0.81 | ALDH1A1 (0.50) | CYP1A2ALDH1A1CYP2A6NCK1BACE1 | |
| SCHEMBL5534632 | 0.81 | ESR2 (0.59) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL8268419 | 0.81 | ALDH1A1 (0.50) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL16070947 | 0.81 | CYP1A2 (0.57) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL5534628 | 0.81 | CYP1A2 (0.57) | CYP1A2CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL12958078 | 0.81 | ALDH1A1 (0.50) | CYP1A2CCR1CCR5CCR8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| EP-4400505-A1 | PEPTIDE-UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF | Bivision Pharmaceuticals, Inc (CN) | 2024-07-17 | — | — | EP | disclosed |
| EP-4398362-A1 | POLYMER SOLID ELECTROLYTE AND APPLICATION | Nanjing Bochi New Energy Co., Ltd. (CN) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024130689-A1 | 2-FLUOROBIPHENYL-4-ACETIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 江苏普莱医药生物技术有限公司 | 2024-06-27 | — | — | WO | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20090066223-A1 | ORGANIC ELECTRIC FIELD LIGHT EMITTING ELEMENT AND PRODUCTION THEREFOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-05-01 | — | — | US | disclosed |
| WO-2008045945-A1 | BENZINDOLE DERIVATIVES AND METHOD OF TREATING HIV/AIDS | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-04-17 | — | — | WO | disclosed |
| US-7250518-B2 | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes | PFIZER INC. (US) | 2007-07-31 | — | — | US | disclosed |
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER INC. (US) | 2007-07-12 | — | — | US | disclosed |
| US-7183293-B2 | Ether derivatives useful as inhibitors of PDE4 isozymes | PFIZER INC. (US) | 2007-02-27 | — | — | US | disclosed |
| EP-0847389-A4 | PROCESS FOR PREPARING QUINOLINE BASES | REILLY IND INC (US) | 2001-04-11 | — | — | EP | disclosed |
| EP-0847389-A1 | PROCESS FOR PREPARING QUINOLINE BASES | REILLY INDUSTRIES, INC. (US) | 1998-06-17 | — | — | EP | disclosed |
| US-5700942-A | Process for preparing quinoline bases | REILLY INDUSTRIES, INC. (US) | 1997-12-23 | — | — | US | disclosed |
| WO-1997003051-A1 | PROCESS FOR PREPARING QUINOLINE BASES | REILLY INDUSTRIES, INC. (US) | 1997-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | CRY1, ARCN1, CORO1A | CYP1A2 2208/4885CCR1 28/4885CCR5 1255/4885 |
| US-20070161681-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PDE4A, PDE4B, PDE4D | CYP1A2 231/4885CCR1 590/4885CCR5 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.